Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C17H15ClN2O |
| Molecular Weight | 298.767 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1(C2=CC=CC=C2N3CCCN=C13)C4=CC=CC(Cl)=C4
InChI
InChIKey=VKQDZNZTPGLGFD-UHFFFAOYSA-N
InChI=1S/C17H15ClN2O/c18-13-6-3-5-12(11-13)17(21)14-7-1-2-8-15(14)20-10-4-9-19-16(17)20/h1-3,5-8,11,21H,4,9-10H2
| Molecular Formula | C17H15ClN2O |
| Molecular Weight | 298.767 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Ciclazindol is an indole derivative and monoamine uptake inhibitor patented by pharmaceutical company John Wyeth and Brother Ltd. as an antidepressant. Besides that, Ciclazindol is effective anorectic agent, inducing weight loss in rats and man. Ciclazindol was shown to inhibit ATP-sensitive K+ (K(ATP)) channel currents and stimulate insulin secretion from CRI-G1 insulin-secreting cells. The inhibition of KATP channel currents by ciclazindol is unaffected by the removal of intracellular Mg2+ ions and after trypsinization of the cytoplasmic surface of excised patches, treatments known to abolish sulphonylurea sensitivity.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:20:25 GMT 2025
by
admin
on
Mon Mar 31 18:20:25 GMT 2025
|
| Record UNII |
Y3I9520J7P
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
37751-39-6
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
Ciclazindol
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
Y-8
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
C79886
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
C009990
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
37825
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
DTXSID50865883
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
SUB06235MIG
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
100000081884
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
Y3I9520J7P
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
CHEMBL1192491
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
3900
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |